Product Tests definition

Product Tests means the definition in clause 4.1;
Sample 1Sample 2Sample 3

Examples of Product Tests in a sentence

  • Product Tests: Tests and inspections that are performed by a nationally recognized testing laboratory (NRTL) according to 29 CFR 1910.7, by a testing agency accredited according to NIST's National Voluntary Laboratory Accreditation Program (NVLAP), or by a testing agency qualified to conduct product testing and acceptable to authorities having jurisdiction, to establish product performance and compliance with specified requirements.

  • Product Tests: Mill certificates or data from a qualified independent testing agency indicating steel sheet complies with requirements, including base-metal thickness, yield strength, tensile strength, total elongation, chemical requirements, and metallic-coating thickness.

  • Each stage is defined by Post-Launch Product Tests (PLPTs), which guide the overall validation process.

  • The NCAC conducts Product Tests for the following:• On behalf of Local Consumer Affairs Centers on request; and• In order to clarify the substantial problems of specific product groups, as well as to raise public awareness.

  • Insiders completing Focus Groups, Product Tests, or Diary Surveys may be eligible to receive Compensation.

  • Refining and adding new Work Product Tests to better verify/evaluate the Staffing Resource’s skill sets.

  • Product Tests: Mill certificates indicating steel sheet complies with requirements, including base-metal thickness, yield strength, tensile strength, total elongation, chemical requirements, and metallic-coating thickness.

  • CONTENTSⅠ．Ten Characteristics of Consumer Counseling in 1999 1.Ⅱ．Report on Results of Product Tests 3Ⅲ．Complaint Verification Test 5Ⅳ．Japan Korea Consumers Forum 6The ratio of counseling cases related to products compared to those related to services was roughly 6 : 4Many complaints about disadvantageous conversion of such contracts were received, citing insufficient explanation given.

  • See Section 1 (Overview) and Appendix A (Post-Launch Product Tests) for more details on the individual PLPT success criteria.‌‌‌‌‌ Collating PLPT results and preparing reports and presentation materials for the Provisional PS- PVR should be done on a rolling basis from Beta onwards so long as Provisional testing is underway.

  • Until such time as the Kinross Facility has achieved Commercial Validation of Performance, Mascoma will assist/consult with Owner’s operating staff during startup, commissioning, and Performance Testing (including travel and living expenses), limited [***] Mascoma full time equivalents (FTEs) providing such support until the earlier of (a) Commercial Validation of Performance, or (b) the exhaustion of all Product Tests.

Related to Product Tests

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Manufacturing Site means the facilities where a Compound is Manufactured by or on behalf of a Party, as such Manufacturing Site may change from time to time in accordance with Section 8.7.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Product Manufacturer means the entity that assembles the component parts to manufacture the final Product;

  • Drug use test means a scientifically substantiated method to test for the presence of illegal or performance-enhancing drugs or the metabolites thereof in a person’s urine.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Finished Product means a cannabis product in its final form to be sold at a retail premises.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Tobacco product manufacturer means an entity that after the date of enactment of this Act directly (and not exclusively through any affiliate):

  • Drug sample means a unit of a prescription drug that is not intended to be sold and is intended to promote the sale of the drug.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Final Product means a reasonably homogenous cannabis product in its final packaged form created using the same standard operating procedures and the same formulation.

  • Commissioning Tests means all of the procedures and tests which, in accordance with the Reasonable and Prudent Standard, and in compliance with industry guidelines, practices and standards, are:

  • Reference biological product means the single biological product licensed pursuant to 42 U.S.C.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Product Labeling means, with respect to a Licensed Product in a country or other jurisdiction in the Territory, (a) the Regulatory Authority‑approved full prescribing information for such Licensed Product for such country or other jurisdiction, including any required patient information, and (b) all labels and other written, printed, or graphic matter upon a container, wrapper, or any package insert utilized with or for such Licensed Product in such country or other jurisdiction.

  • Licensed Compound means [***].

  • Drug test means a test designed to detect the illegal use of a controlled substance.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • product type means any of the following:

  • API means the American Petroleum Institute.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.